COMBINATION VACCINES AGAINST CORONAVIRUS INFECTION, INFLUENZA INFECTION, AND/OR RSV INFECTION

INFLUENZA B VIRUS REPLICATION FOR VACCINE DEVELOPMENT

MRNA ENCODING INFLUENZA VIRUS-LIKE PARTICLE

POLYPEPTIDE FRAGMENTS, IMMUNOGENIC COMPOSITION AGAINST INFLUENZA VIRUS, AND IMPLEMENTATIONS THEREOF

MULTIVALENT DISPLAY ON ENVELOPED PARTICLES WITH HUMAN OLIGOMERIZATION DOMAINS

NUCLEIC ACID CONSTRUCT AND USE THEREOF

NOVEL INFLUENZA ANTIGENS

INFLUENZA VIRUS HEMAGGLUTININ PROTEINS AND USES THEREOF

MODIFIED INFLUENZA B HEMAGGLUTININ POLYPEPTIDES AND NUCLEIC ACIDS AND USES THEREOF

Multicistronic Vaccine and Methods for Producing and Using the Same

Influenza virus hemagglutinin proteins and uses thereof

TEMPERATURE-CONTROLLABLE, SELF-REPLICATING RNA VACCINES FOR VIRAL DISEASES

INFLUENZA VIRUS NUCLEIC ACID LIPID PARTICLE VACCINE

INFLUENZA VACCINE COMPOSITIONS AND METHODS OF USING SAME

Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses

INFLUENZA VACCINE COMPOSITIONS AND METHODS OF USING SAME

INFLUENZA B VIRUS MUTANTS AND USES THEREFOR

Vaccine compositions having improved stability and immunogenicity

Methods of optimizing nucleotide sequences encoding engineered influenza proteins

Influenza virus hemagglutinin proteins and uses thereof

Engineered influenza antigenic polypeptides and immunogenic compositions thereof

INFLUENZA B VIRUS REPLICATION FOR VACCINE DEVELOPMENT

Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites and methods of use thereof

HIGH GROWTH INFLUENZA VIRUS

INFLUENZA VIRUS-LIKE PARTICLE PRODUCTION IN PLANTS

Plant expression enhancer

Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses

Methods of optimizing nucleotide sequences encoding engineered influenza proteins

Vaccines for human papilloma virus and methods for using the same

Influenza peptides and compositions

H7 avian influenza vaccine strain which differentiates infected from vaccinated animals, preparation method therefor, and application

Influenza B virus mutants and uses therefor

Influenza virus-like particle production in plants

Headless hemagglutin influenza vaccine

Engineered influenza antigenic polypeptides and immunogenic compositions thereof

Vaccine compositions having improved stability and immunogenicity

Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites and methods of use thereof

Influenza virus hemagglutinin proteins and uses thereof

NOVEL SYNTHETIC ANTICANCER, ANTIFUNGAL, AND ANTIBACTERIAL VACCINES

Influenza peptides and compositions

Vaccines for human papilloma virus and methods for using the same

Recombinant influenza virus-like particles (VLPS) produced in transgenic plants

Antiviral peptide and use therefor

Computationally optimized broadly reactive antigens for human and avian H5N1 influenza

Method for producing RNA molecule compositions

Highly efficient influenza matrix (M1) proteins

Compact bypass and decoupling structure for millimeter-wave circuits

INFLUENZA NUCLEIC ACID MOLECULES AND VACCINES MADE THEREFROM

Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites and methods of use thereof

Engineered influenza antigenic polypeptides and immunogenic compositions thereof

Reverse genetics systems

Peptide sequences and compositions

Methods of optimizing nucleotide sequences encoding engineered influenza proteins

Peptide sequences and compositions

Vaccine compositions having improved stability and immunogenicity

NOVEL SYNTHETIC ANTICANCER, ANTIFUNGAL, AND ANTIBACTERIAL VACCINES

Compositions and methods for increasing immunogenicity of glycoprotein vaccines

Influenza B virus replication for vaccine development

Highly efficient influenza matrix (M1) proteins

Vaccine compositions having improved stability and immunogenicity

Computationally optimized broadly reactive antigens for human and avian H5N1 influenza

Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin

Influenza antigen delivery vectors and constructs

Peptide sequences and compositions

Identification and attenuation of the immunosuppressive domains in fusion proteins of enveloped RNA viruses

ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS

Influenza virus-like particle production in plants

Vaccines for human papilloma virus and methods for using the same

Influenza nucleic acid molecules and vaccines made therefrom

Computationally optimized broadly reactive antigens for human and avian H5N1 influenza

Broadly reactive mosaic peptide for influenza vaccine

Highly efficient influenza matrix (M1) proteins

Influenza virus vaccines and uses thereof

Flagellin Fusion Proteins

Flagellin fusion proteins

Deletion mutants of flagellin and methods of use

Deletion mutants of flagellin and methods of use

Virus-like particles comprising a matrix protein from a plant enveloped virus and uses thereof

Computationally optimized broadly reactive antigens for H3N2, H2N2, and B influenza viruses

Compositions and methods for treating influenza

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

Fusion proteins and methods of use

Influenza antigen delivery vectors and constructs

Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds

Influenza B viruses having alterations in the hemagglutinin polypeptide

Multi plasmid system for the production of influenza virus

Fusion proteins and methods of use

Peptide sequences and compositions

Methods of making hemagglutinin proteins

Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin

Methods of treatment with compositions that include hemagglutinin

Crystal structure of amino terminal portion of influenza virus polymerase PA subunit and use thereof

Highly efficient influenza matrix (M1) proteins

Reassortant influenza B viruses

Multi plasmid system for the production of influenza virus

Reverse genetics systems

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

Influenza viruses and uses thereof

COMBINATION VACCINES AGAINST RESPIRATORY TRACT DISEASES

VIRUS LIKE PARTICLES COMPRISING TARGET PROTEINS FUSED TO PLANT VIRAL COAT PROTEINS

Peptide sequences and compositions

Chimeric influenza virus-like particles comprising hemagglutinin

Influenza hemagglutinin and neuraminidase variants

INFLUENZA A AND B VIRUS REPLICATION-INHIBITING PEPTIDES

POLYPEPTIDE CARRIER PROTEIN

Influenza vaccine

INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS

Multi plasmid system for the production of influenza virus

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER

DNA transfection system for the generation of negative strand RNA virus

Deletion mutants of flagellin and methods of use

Crystal structure of the influenza virus polymerase PAC-PB1complex and uses thereof

Compositions that Include Hemagglutinin, Methods of Making and Methods of Use Thereof

Claudin-4 binding peptides, compositions and methods of use

Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds

INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS

MULTIFUNCTIONAL LINKER PROTEIN CONTAINING AN ANTIBODY AGAINST HEMAGGLUTININ, A CONSERVED INFLUENZA ANTIGEN AND AN IMMUNOSTIMULATING CARRIER BINDING DOMAIN

Influenza Vaccines Containing Hemagglutinin and Matrix Proteins

CHIMERIC VARICELLA ZOSTER VIRUS VIRUS-LIKE PARTICLES

System for the heterologous expression of a viral protein in a ciliate host cell

Influenza hemagglutinin and neuraminidase variants

Modified influenza virus

Influenza B viruses having alterations in the hemaglutinin polypeptide

RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES (VLPS) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ

Influenza virus vaccines and uses thereof

Vaccines comprising an immunostimulatory peptide and an immunostimulatory oligodeoxynucleic acid molecule

NUCLEIC ACID SEQUENCES FOR THE AMPLIFICATION AND DETECTION OF RESPIRATORY VIRUSES

VIRUSES ENCODING MUTANT MEMBRANE PROTEIN

Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds

NOVEL METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE PROPAGATION OF VIRUSES

Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza

Avian influenza chimeric VLPS

ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS

Compositions and methods for increasing immunogenicity of glycoprotein vaccines

VACCINE COMPOSITIONS OF M2e, HA0 AND BM2 MULTIPLE ANTIGENIC PEPTIDES

PROCESS FOR DESIGNING INHIBITORS OF INFLUENZA VIRUS STRUCTURAL PROTEIN-1

Peptide sequences and compositions

Assay for the separation and quantification of hemagglutinin antigens

METHODS AND COMPOSITIONS FOR PREDICTING AND TREATING DRUG RESISTANT STRAINS OF INFLUENZA VIRUS

Signal for packaging of influenza virus vectors

Influenza vaccine

Multi plasmid system for the production of influenza virus

INFLUENZA NUCLEIC ACIDS, POLYPEPTIDES, AND USES THEREOF

Influenza virus neuraminidase crystal structure and their use thereof

Polypeptide carrier protein

Methods for the propagation of modified influenza viruses in embryonated eggs

Influenza antigen delivery vectors and constructs

Influenza Hemagglutinin And Neuraminidase Variants

Method for producing temperature sensitive influenza A viruses

Influenza Hemagglutinin And Neuraminidase Variants

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

Polyvalent influenza virus-like particle (VLP) compositions

DNA-transfection system for the generation of infectious influenza virus

DNA-transfection system for the generation of infectious influenza virus

Influenza B viruses with reduced sensitivity to neuraminidase inhibitors

Process for Designing Inhibitors of Influenza Virus Structural Protein 1

DNA-transfection system for the generation of infectious influenza virus

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER

Compositions and methods for the therapy and diagnosis of prostate cancer

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER

Production of viruses, viral isolates and vaccines

Multiple antigenic agents and methods for using the same

Intranasal or inhalational administration of virosomes

Compositions that include hemagglutinin

Compositions that include hemagglutinin, methods of making and methods of use thereof

Assay for the separation and quantification of hemagglutinin antigens

Cold-adapted (CA) reassortant influenza virus

Signal for packaging of influenza virus vector

Influenza vaccine

Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds

Polyepitope carrier protein

Vaccines

Influenza hemagglutinin and neuraminidase variants

Influenza nucleic acids, polypeptides, and uses thereof

Assay for the separation and quantification of hemagglutinin antigens

Molecular methods and compositions for detecting and quantifying respiratory viruses

Multi plasmid system for the production of influenza virus

DNA transfection system for the generation of infectious influenza virus

Production of viruses viral isolates and vaccines

Methods and interferon deficient substrates for the propagation of viruses

Influenza hemagglutinin and neuraminidase variants

Stabilized hemagglutinin (HA) trimers as influenza vaccine antigens